#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2156127	F	Antagonist activity at human GPR91 receptor expressed in CHO-K1 cells co-expressing Galpha and Gqi5 G-protein assessed as inhibition of succinate-induced increase in intracellular calcium level by FLIPR assay	Homo sapiens	47		cell-based format	Scientific Literature
2.	ALA2155421	A	Intrinsic clearance in rat liver microsomes preincubated for 5 mins before addition of NADPH measured after 30 mins by LC/MS/MS analysis	Rattus norvegicus	51		microsome format	Scientific Literature
3.	ALA2155423	F	Antagonist activity at rat GPR91 receptor expressed in CHO-K1 cells co-expressing Galpha and Gqi5 G-protein assessed as inhibition of succinate-induced increase in intracellular calcium level by FLIPR assay	Rattus norvegicus	6		cell-based format	Scientific Literature
4.	ALA2155424	F	Antagonist activity at human GPR99 receptor expressed in CHO-K1 cells co-expressing Galpha and Gqi5 G-protein assessed as inhibition of succinate-induced increase in intracellular calcium level at by FLIPR assay	Homo sapiens	8		cell-based format	Scientific Literature
5.	ALA2155425	A	Cmax in Wistar rat at 5 mg/kg, iv by LC/MS/MS analysis	Rattus norvegicus	7		organism-based format	Scientific Literature
6.	ALA2155426	A	Plasma clearance in Wistar rat at 5 mg/kg, iv	Rattus norvegicus	7		organism-based format	Scientific Literature
7.	ALA2155427	A	Volume of distribution at steady state in Wistar rat at 5 mg/kg, iv	Rattus norvegicus	7		organism-based format	Scientific Literature
8.	ALA2155428	A	Terminal half life in Wistar rat at 5 mg/kg, iv	Rattus norvegicus	7		organism-based format	Scientific Literature
9.	ALA2155429	A	Cmax in Wistar rat at 50 mg/kg, ip by LC/MS/MS analysis	Rattus norvegicus	4		organism-based format	Scientific Literature
10.	ALA2155430	A	Tmax in Wistar rat at 50 mg/kg, ip	Rattus norvegicus	4		organism-based format	Scientific Literature
11.	ALA2155431	A	AUC (0 to 8 hrs) in Wistar rat plasma at 50 mg/kg, ip	Rattus norvegicus	4		organism-based format	Scientific Literature
12.	ALA2155432	A	Plasma concentration in Wistar rat plasma at 50 mg/kg, ip at 2 hrs	Rattus norvegicus	3		organism-based format	Scientific Literature
13.	ALA2155433	A	Plasma concentration in Wistar rat plasma at 50 mg/kg, ip at 4 hrs	Rattus norvegicus	3		organism-based format	Scientific Literature
14.	ALA2155434	A	Plasma concentration in Wistar rat plasma at 50 mg/kg, ip at 8 hrs	Rattus norvegicus	4		organism-based format	Scientific Literature
15.	ALA2155518	A	Drug concentration in Wistar rat kidney at 50 mg/kg, ip after 4 hrs	Rattus norvegicus	1		organism-based format	Scientific Literature
16.	ALA2155520	F	Hypotensive activity in Wistar rat assessed as inhibition of succinate-induced increase in mean arterial pressure at 50 mg/kg, ip after 2 hrs post dose	Rattus norvegicus	1		organism-based format	Scientific Literature
17.	ALA2155521	F	Hypotensive activity in Wistar rat assessed as inhibition of succinate-induced increase in mean arterial pressure at 50 mg/kg, ip after 4 hrs post dose	Rattus norvegicus	1		organism-based format	Scientific Literature
18.	ALA2155524	A	Plasma protein binding in Wistar rat at 50 mg/kg, ip	Rattus norvegicus	1		organism-based format	Scientific Literature
19.	ALA3301368	A	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Mus musculus	162		cell-free format	AstraZeneca Deposited Data
20.	ALA3301372	A	ASTRAZENECA: Intrinsic clearance measured in human hepatocytes following incubation at 37C. Experimental range <3 to >150 microL/min/1E6 cells. Rapid Commun. Mass Spectrom. 2010, 24, 1730-1736.	Homo sapiens	408		cell-based format	AstraZeneca Deposited Data